Drooid Logo
Back to today’s briefing

Story perspectives

Experts Warn: Self-Administered Peptides Risky Amid FDA Review

4/17/2026

37 6 Full Breakdown

1 of 1

Story summary
  • A rising number of Americans self-administer peptides purchased online, often without understanding their contents.
  • Pinchas Cohen, a scientist at the University of Southern California, warns that peptides should be used only under medical supervision.
  • Cohen's lab identifies MOTS-c, a peptide with ties to Jewish tradition.
  • The FDA is considering easing restrictions on peptide injections.